Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Trends in Biotechnology|August 24, 2024
Harmonizing the symphony of chimeric antigen receptor T cell immunotherapy with the elegance of biomaterialsZhaozhao Chen, Yu Hu, Heng MeiBriefings in Functional Genomics|January 18, 2020
Applications and explorations of CRISPR/Cas9 in CAR T-cell therapyChenggong Li, Heng Mei, Yu HuJournal of Hematology & Oncology|December 2, 2020
Thrombocytopenia and thrombosis in hospitalized patients with COVID-19Heng Mei, Lili Luo, Yu HuAdvanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 31, 2023
Advances in CAR-Engineered Immune Cell Generation: Engineering Approaches and Sourcing StrategiesZhaozhao Chen, Yu Hu, Heng MeiYi Chuan Xue Bao = Acta Genetica Sinica|December 23, 2006
Powers of multiple-testing procedures for identification of genes significantly differentially expressed in microarray experimentsYuan-De Tan, Heng-Mei YanBiomarker Research|December 9, 2020
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?Huiwen Jiang, Yu Hu, Heng MeiExperimental Hematology & Oncology|March 18, 2026
Prospects and advances of PROTAC in the treatment of hematologic malignanciesXinyang Wang, Ming Zhang, Heng MeiPharmaceuticals (Basel, Switzerland)|January 26, 2024
Harnessing Biomaterials for Safeguarding Chimeric Antigen Receptor T Cell Therapy: An Artful Expedition in Mitigating Adverse EffectsZhaozhao Chen, Yu Hu, Heng MeiJournal of Hematology & Oncology|May 6, 2024
Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies: latest update from ASH 2023 annual meetingYun Kang, Chenggong Li, Heng MeiMedicine|May 4, 2026
Novel oral chidamide and valganciclovir regimen for EBV-PTLD post-hematopoietic stem cell transplantation: A case reportYaogong Wu, Zhaodong Zhong, Heng MeiPageof 19